MEDICAL AND COST EFFECTIVENESS OF BARIATRIC SURGERY IN OBESITY. RESULTS OF AN HTA COMMISIONED BY THE GERMAN AGENY FOR HEALTH TECHNOLOGY ASSESSMENT
Author(s)
Christoph Vauth, MSc, Head Health Technology Unit1, Yvonne Stöber, MSc, Research Fellow1, Angelina Bockelbrink, PhD, Research Fellow2, Wolfgang Greiner, PhD, Professor for Health Economics and Health Care Management31Leibniz University Hannover, Hannover, Germany; 2 Charité University Medical Center, Berlin, Germany; 3 University of Bielefeld, Bielefeld, Germany
OBJECTIVES: Health Technology Assessment to evaluate the medical effectiveness and cost-effectiveness of bariatric surgical procedures in the therapy of morbid obesity in adults compared to standard interventions. METHODS: Systematic literature review (published since 2001), targeting adult subjects with morbid obesity (BMI >= 40 kg / m² or BMI >= 35 kg / m² with severe comorbidities). Relevant publications are identified by means of a structured search of 28 databases (e.g. Medline, Embase, Cochrane Central) on November 12th, 2007. In addition a manual search of identified reference lists was conducted. Titles and abstracts of the identified publications have been independently screened by two experts on evidence based medicine and health economics. The methodological quality of included studies have been assessed using the criteria recommended by the Scottish Intercollegiate Guideline Network (SIGN) Grading Review Group. Randomised as well as non-randomised studies are included, case reports and series are not considered. The methodological quality of the economic publications has been assesed using checklists of the German Scientific Working Group of Technology Assessment for Health Care and the methodological guide of the EURONHEED project. RESULTS: Among 5910 retrieved publications, 25 medical articles and seven health economic studies met the inclusion criteria. Among the included medical publications are nine RCTs, 13 papers on non-randomised clinical trials, and three systematic reviews with meta-analysis. Within the economic assessment, three CEA and four systematic reviews have been identified. Three of the non-randomised studies assess bariatric vs. conventional procedures. All other studies compare different surgical procedures among each other. Follow-up time varies between one and five years in the RCT and goes up to eleven years in one clinical trial. Both medical studies assessing effectiveness of bariatric vs. conventional procedures show a significant greater weight loss after surgery and decline in comorbidities. Diabetes incidence after ten years is lower in the surgery group, but no significant differences can be seen for hypertension, dislipoproteinemia.Among the economics publications, three studies evaluated the cost-effectiveness of certain bariatric surgeries. One study examined two bariatric operations, adjustable gastric banding and gastric bypass, for the treatment of obesity in patients with Type 2 diabetes mellitusOne of the studies included deals with a comparison of GBP vs. no treatment, whereas the other compares the two surgical procedures VBG and AGB among each other. Furthermore, four systematic literature reviews are among the included economic publications, estimating the cost-effectiveness of bariatric treatments based on published data. The focus of the reviews lies both, on the comparison of the cost-effectiveness among the bariatric procedures, as well as on the comparison to no treatment at all. CONCLUSIONS: The short and medium term effectiveness of bariatric procedures on weight loss can be assumed and is cost-effective. The weight loss is generally accompanied by a reduction of comorbidities, in particular diabetes, and a decreased overall mortality. There is a lack of studies that focus long term effects and costs. Therefore, based on the available literature no recommendation can be given with respect to the choice of a certain bariatric procedure in usual care or to the selection of particular groups of patients. However, the present results can be seen as a basis for discussion about the very restrictive practice regarding decisions on reinbursability of bariatric procedures. Further more, comprehensive quality assurance is needed, including the implementation of competence centres and the fixing of minimum amounts for procedures. In this context the long term assessment and evaluation of all patients and their course of disease is necessary, aiming at the highest possible effectiveness of medical treatment and still allowing for economic limits.
Conference/Value in Health Info
2008-11, ISPOR Europe 2008, Athens, Greece
Value in Health, Vol. 11, No. 6 (November 2008)
Code
PSY19
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Diabetes/Endocrine/Metabolic Disorders